EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents

MC Arendrup, Joseph Meletiadis, Johan Mouton, J Guinea, M Cuenca-Estrella, K Lagrou, SJ Howard

Research output: Contribution to journalArticleAcademic

89 Citations (Scopus)

Abstract

The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E. Def 7.3, E. Def 9.2 and E. Def 9.3 method documents (http://www.eucast.org). (C) 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Original languageUndefined/Unknown
JournalClinical Microbiology and Infection
Volume22
Issue number6
DOIs
Publication statusPublished - 2016

Cite this